- Home
- MRBK vs NVCT Comparison
MRBK vs NVCT Comparison
Compare MRBK & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRBK
- NVCT
- Stock Information
- Founded
- MRBK 2004
- NVCT 2020
- Country
- MRBK United States
- NVCT United States
- Employees
- MRBK N/A
- NVCT N/A
- Industry
- MRBK Major Banks
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- MRBK Finance
- NVCT Health Care
- Exchange
- MRBK Nasdaq
- NVCT Nasdaq
- Market Cap
- MRBK 162.3M
- NVCT 167.0M
- IPO Year
- MRBK 2017
- NVCT 2022
- Fundamental
- Price
- MRBK $14.41
- NVCT $5.99
- Analyst Decision
- MRBK Buy
- NVCT Strong Buy
- Analyst Count
- MRBK 2
- NVCT 3
- Target Price
- MRBK $17.50
- NVCT $15.33
- AVG Volume (30 Days)
- MRBK 48.6K
- NVCT 112.8K
- Earning Date
- MRBK 10-23-2025
- NVCT 11-04-2025
- Dividend Yield
- MRBK 3.47%
- NVCT N/A
- EPS Growth
- MRBK 75.95
- NVCT N/A
- EPS
- MRBK 1.77
- NVCT N/A
- Revenue
- MRBK $109,758,000.00
- NVCT N/A
- Revenue This Year
- MRBK $26.84
- NVCT N/A
- Revenue Next Year
- MRBK $8.90
- NVCT N/A
- P/E Ratio
- MRBK $8.15
- NVCT N/A
- Revenue Growth
- MRBK 18.84
- NVCT N/A
- 52 Week Low
- MRBK $11.16
- NVCT $4.44
- 52 Week High
- MRBK $17.33
- NVCT $11.52
- Technical
- Relative Strength Index (RSI)
- MRBK 43.57
- NVCT 46.38
- Support Level
- MRBK $14.35
- NVCT $5.86
- Resistance Level
- MRBK $14.88
- NVCT $6.21
- Average True Range (ATR)
- MRBK 0.38
- NVCT 0.33
- MACD
- MRBK -0.01
- NVCT -0.01
- Stochastic Oscillator
- MRBK 30.46
- NVCT 35.20
About MRBK Meridian Corporation
Meridian Corp is a bank holding company. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three reportable segments including Bank, Wealth, and Mortgage. The company generates maximum revenue from the Bank segment which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.